This month’s articles:
Latest articles
First patients receive gene therapy for blindness on NHS
The first patients have begun gene therapy for blindness on the NHS as part of NHS Long Term Plan. Babies born with an inherited retinal...
Pharma marketing authorisations, approvals and appraisals
Pf rounds up this week's pharma marketing authorisations, approvals and appraisals, featuring news from the UK, EU, Japan and the USA. UK Kyowa Kirin International announced...
UK Life Science Opportunity Zones announced
The Office for Life Sciences has announced six new locations that have been awarded the prestigious status of Life Science Opportunity Zone (LSOZ), helping...
Popular articles
UK Life Science Opportunity Zones announced
The Office for Life Sciences has announced six new locations that have been awarded the prestigious status of Life Science Opportunity Zone (LSOZ), helping...
Pharma R&D is leading the way for UK
The latest research by RIFT Research and Development Ltd has revealed which UK companies are driving business forward in their respective sectors through research and...
Pharma marketing authorisations, approvals and appraisals
Pf rounds up this week's pharma marketing authorisations, approvals and appraisals, featuring news from the UK, EU, Japan and the USA. UK Kyowa Kirin International announced...
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Innovation Scholars Scheme to support collaboration between researchers and industry
A new £10m Innovation Scholars Scheme will give leading researchers and businesses, based in the UK, the chance to work together to develop treatments...